Business
Galderma Announces Departure of Its Chief Financial Officer
ZUG, Switzerland, July 01, 2025--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that Thomas Dittrich, Chief Financial Officer, will be leaving the company to pursue another senior executive opportunity outside the organization.
About this update from Galderma Group Ag
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":823,"height":209,"url":"https://media.zenfs.com/en/business-wire.com/32886a15b2c9adfa89a4572b1e30c042"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/TBYbGo.S7DfxVti7weYicQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI0NDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/32886a15b2c9adfa89a4572b1e30c042","width":823,"height":209},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/nRckTPTw8ck53QU..8wFWA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE2NDY7aD00MTg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/32886a15b2c9adfa89a4572b1e30c042","width":823,"height":209}},"lazy":false},{"type":"text","content":"Ad hoc announcement pursuant to Art. 53 LR","length":42,"tagName":"p"},{"type":"text","content":"ZUG, Switzerland, July 01, 2025--(BUSINESS WIRE)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that Thomas Dittrich, Chief Financial Officer, will be leaving the company to pursue another senior executive opportunity outside the organization.","length":286,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"1","rowspan":"1","style":"vertical-align:top;background-color:#CCEEFF;padding-left:5.0px;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}},{"type":"text","content":""We thank Thomas for his financial leadership and many contributions during his time at Galderma. He played a key role in establishing the financial discipline, operational readiness, and strategic clarity that will continue to guide us forward. We wish him every success in his next role and remain focused on further accelerating Galderma’s strong growth – from category leadership to becoming a true powerhouse in dermatology."","length":440,"tagName":"p","attribs":{}},{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}},{"type":"text","content":"FLEMMING ØRNSKOV, M.D., MPH","length":27,"tagName":"p","attribs":{}},{"type":"text","content":"CHIEF EXECUTIVE OFFICER","length":23,"tagName":"p","attribs":{}},{"type":"text","content":"GALDERMA","length":8,"tagName":"p","attribs":{}},{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]}]}],"length":504},{"type":"text","content":"Thomas Dittrich will ...